Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in patients with primary brain tumors: a prospective cohort study

PURPOSE: Immunogenicity of Covid-19 vaccines may be negatively impacted by anti-cancer treatment. The management of primary brain tumors (PBTs) routinely includes temozolomide and steroids, which are immune-suppressive. We aimed to determine the rate of seropositivity in PBT patients following recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Massarweh, Amir, Tschernichovsky, Roi, Stemmer, Amos, Benouaich-Amiel, Alexandra, Siegal, Tali, Eliakim-Raz, Noa, Stemmer, Salomon M., Yust-Katz, Shlomit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752179/
https://www.ncbi.nlm.nih.gov/pubmed/35018613
http://dx.doi.org/10.1007/s11060-021-03911-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752179/
https://www.ncbi.nlm.nih.gov/pubmed/35018613
http://dx.doi.org/10.1007/s11060-021-03911-7

Ejemplares similares